FAQ
Glossary

Fermer

FAQ

Why are some conditions more suitable for gene and cell therapies than others?

There is an approved treatment available for my condition - why can't I receive it?

How to look for approved medicines?

How are medicines developed and approved?

Voir toutes les FAQ

Fermer

Glossary

Adeno-associated virus (AAV)

Adult stem cells

Chimeric Antigen Receptor (CAR)

Voir le glossaire complet

Quality Flowchart

European Medicines Agency (EMA) has published a guide to help gene and cell therapy developers navigate the most important quality-related regulatory requirements.

EMA quality flowchart

Follow the link to quality flowchart and checklist:

EMA quality flowchart

Back to EMA Resources

Retour en haut de page

Le contenu de cette page vous a-t-il été utile ? Envoyez-nous vos commentaires